Mtengo wa FGFR

MPAKA # Dzina lazogulitsa Kufotokozera
Chithunzi cha CPD100464 Erdafitinib Erdafitinib, yomwe imadziwikanso kuti JNJ-42756493, ndi yamphamvu komanso yosankha pamlomo bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor yomwe ingakhale ndi ntchito ya antineoplastic. Pogwiritsa ntchito pakamwa, JNJ-42756493 imamangiriza ndikuletsa FGFR, zomwe zingayambitse kulepheretsa njira zotumizira zizindikiro zokhudzana ndi FGFR ndipo motero kulepheretsa kufalikira kwa maselo a chotupa ndi imfa ya maselo a chotupa mu FGFR-overexpressing chotupa maselo. FGFR, yokhazikika mumitundu yambiri yama cell chotupa, ndi receptor tyrosine kinase yofunikira pakuchulukira kwa maselo a chotupa, kusiyanitsa ndi kupulumuka.
Chithunzi cha CPD3618 TAS-120 TAS-120 ndi orally bioavailable inhibitor ya fibroblast growth factor receptor (FGFR) yokhala ndi ntchito yoletsa antiineoplastic. FGFR inhibitor TAS-120 mosankha komanso mosasinthika imamangiriza ndi kuletsa FGFR, zomwe zingapangitse kuletsa kwa njira yopatsira ma siginecha ya FGFR ndi kuchuluka kwa maselo otupa, komanso kuchuluka kwa kufa kwa maselo mu FGFR-ma cell chotupa ochulukirapo. FGFR ndi receptor tyrosine kinase yofunikira pakuchulukira kwa maselo a chotupa, kusiyanitsa ndi kupulumuka ndipo mawonekedwe ake amayendetsedwa mumitundu yambiri yama cell chotupa.
Mtengo wa CPDB1093 Derazantinib; Chithunzi cha ARQ-087 Derazantinib, yomwe imadziwikanso kuti ARQ-087, ndi inhibitor yapakamwa ya bioavailable ya fibroblast growth factor receptor (FGFR) yokhala ndi zochita za antiineoplastic.
Mtengo wa CPDB0942 BLU-554 BLU-554 ndi fibroblast growth factor receptor 4 (FGFR4) inhibitor yomwe ingathe kuchiza hepatocellular carcinoma ndi cholangiocarcinoma.
CPD0999 H3B-6527 H3B-6527 (H3 Biomedicine) ndiwosankha kwambiri FGFR4 inhibitor yokhala ndi zochita zamphamvu zotsutsana ndi zotupa mu FGF19 amplified cell lines ndi mbewa.
CPD0997 Chithunzi cha FGF401 FGF-401 ndi inhibitor ya FGFR4 yotengedwa ku patent WO2015059668A1, pawiri chitsanzo 83; ili ndi IC50 ya 1.9 nM.
Mtengo wa CPDB0053 AZD4547 AZD 4547 ndi inhibitor yosankha ya fibroblast growth factor receptor (FGFR) tyrosine kinase yokhala ndi IC50 yamtengo wapatali ya 0.2, 2.5, ndi 1.8 nM ya FGFR1, 2, ndi 3, motsatira.
Chithunzi cha CPD3610 BLU-9931 BLU9931 ndi yamphamvu, yosankha, komanso yosasinthika FGFR4 inhibitor yokhala ndi IC50 ya 3 nM, pafupifupi 297-, 184-, ndi 50-fold selectivity pa FGFR1/2/3, motsatana.
ndi

Lumikizanani nafe

Kufunsa

Nkhani zaposachedwa

  • Zochita 7 Zapamwamba Pakufufuza Zamankhwala Mu 2018

    Zochita 7 Zapamwamba Pakufufuza Kwamankhwala Ine...

    Pokhala pansi pa chikakamizo chochulukirachulukira chopikisana nawo m'malo ovuta azachuma ndi ukadaulo, makampani opanga mankhwala ndi biotech akuyenera kupitiliza kupanga mapulogalamu awo a R&D kuti akhale patsogolo ...

  • ARS-1620: Cholepheretsa chatsopano cha khansa ya KRAS-mutant

    ARS-1620: Cholepheretsa chatsopano cha K...

    Malinga ndi kafukufuku yemwe adasindikizidwa mu Cell, ofufuza apanga choletsa china cha KRASG12C chotchedwa ARS-1602 chomwe chimapangitsa kuti chotupa chiziyenda bwino mu mbewa. "Kafukufukuyu akupereka umboni wosonyeza kuti mutant KRAS ikhoza kukhala ...

  • AstraZeneca ilandila kulimbikitsidwa kwamankhwala a oncology

    AstraZeneca ilandila kulimbikitsidwa kwa ...

    AstraZeneca idalimbikitsidwa kawiri pazamankhwala ake a oncology Lachiwiri, pambuyo poti olamulira aku US ndi ku Europe avomereza kuwongolera kwamankhwala ake, gawo loyamba lopambana kuvomerezedwa kwa mankhwalawa. ...

Macheza a WhatsApp Paintaneti!